Many people in the US are being over-diagnosed and over-treated for cancer and better definitions of cancer and new molecular diagnostic technologies could help solve the problem, according to a working group of the National Cancer Institute.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

In a Name

Arsenic Adaptation

Provision Cost

The Genetics of Pot

Things Not Found

The San Diego Union Tribune wonders whether Medicare is ready for personalized medicine.

Jun Wang, the chief executive of BGI, has stepped down.

In PNAS this week: human T cell editing with CRISPR, retrotransposons acting as insulators, and more.

The New York Times' George Johnson muses on cancer's roots in multicellularity.